Logo image
Standalone Endovascular Embolization versus Stereotactic Radiosurgery in the Treatment of Arteriovenous Malformations in Eloquent Brain
Journal article   Peer reviewed

Standalone Endovascular Embolization versus Stereotactic Radiosurgery in the Treatment of Arteriovenous Malformations in Eloquent Brain

Basel Musmar, Hammam Abdalrazeq, Nimer Adeeb, Hamza Adel Salim, Joanna M Roy, Assala Aslan, Stavropoula I Tjoumakaris, Christopher S Ogilvy, Mustafa K Baskaya, Douglas Kondziolka, …
Radiology, Vol.317(1), p.e250329
10/2025
PMID: 41117652

Abstract

Adult Angiography, Digital Subtraction Embolization, Therapeutic - methods Female Humans Intracranial Arteriovenous Malformations - diagnostic imaging Intracranial Arteriovenous Malformations - therapy Male Middle Aged Radiosurgery - methods Retrospective Studies Treatment Outcome Young Adult
Background Arteriovenous malformations (AVMs) in eloquent brain regions pose significant challenges due to the increased risk of neurologic deficits associated with treatment. Although stereotactic radiosurgery (SRS) and endovascular embolization are used as standalone approaches, their comparative outcomes in eloquent brain AVMs remain unclear. Purpose To directly compare the outcomes of standalone endovascular embolization versus SRS for patients with AVMs in the eloquent brain. Materials and Methods This retrospective multicenter study analyzed patients with AVMs located in eloquent brain regions treated with standalone SRS or embolization from January 2010 to December 2023 as part of the Multicenter International Study for Treatment of Brain AVMs, or MISTA, consortium. Angiographic outcomes were assessed using digital subtraction arterial angiography, MR angiography, or CT angiography. Propensity score weighting (PSW) was used to account for baseline differences. Results A total of 119 patients were included (median age, 35 years [IQR, 21-54 years]; 64 female), with 96 patients treated with SRS and 23 with embolization. SRS achieved 71% (61 of 86 patients) complete obliteration at last follow-up compared with 56% (10 of 18 patients) in the embolization group (odds ratio [OR], 1.95; = .20) before adjustment. After PSW, SRS achieved higher odds of complete obliteration at last follow-up (OR, 15.58; = .001) compared with embolization. Before PSW, the SRS group had higher rates of modified Rankin Scale (mRS) scores 0-2 at last follow-up (95% [86 of 91 patients] vs 71% [15 of 21 patients]; OR, 6.8; = .004) and a lower rate of hemorrhagic complications (5.2% [five of 96 patients] vs 26% [six of 23 patients]; OR, 0.15; = .005) compared with embolization. Mortality rates were 2.1% (two of 96) in the SRS group and 4.3% (one of 23) in the embolization group (OR, 0.46; = .54). After PSW, there was no evidence of a difference between SRS and embolization in mRS scores 0-2 (OR, 2.04; = .45) or hemorrhagic complications (OR, 0.60; = .63). Conclusion SRS was associated with a higher obliteration rate compared with embolization in patients with eloquent brain AVMs, whereas there was no evidence of a difference in functional outcomes or complications after adjustment. © RSNA, 2025 See also the editorial by Russell in this issue.

Details

Logo image